When was Biotricity founded?

Biotricity was founded in 2014 and raised its 1st funding round 2 years after it was founded.

Where is Biotricity located?

Biotricity is headquartered in San Francisco, United States.

Who is the current CEO of Biotricity?

Waqaas Al-Siddiq of Biotricity. They have also founded 1 company.

How many employees does Biotricity have?

As of Apr 30, 2026, the latest employee count at Biotricity is 56.

Is Biotricity a funded company?

Biotricity is a funded company, having raised an undisclosed amount across 6 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Feb 22, 2016.

When was the latest funding round of Biotricity?

Biotricity's latest funding was a $***** Post IPO round on Mar 25, 2024, with participation from 0 investor. Its primary sector is Cardiac and Vascular Disorders. In United States, the Cardiac and Vascular Disorders sector has seen $852M in funding in 2026 to date.

What is the annual revenue of Biotricity?

Annual revenue of Biotricity is $13.8M as on Mar 31, 2025.

Where does Biotricity rank among its competitors?

Biotricity ranks 9th amongst 755 active competitors, of which 178 are funded. It stands 10th in terms of total funding among its competitors. The most recent competitor to raise funding was Nyxoah, which secured $26.4M in Dec, 2025.

Who are the top competitors of Biotricity?

Biotricity's top competitors include Withings, iRhythm Tech and Eko. Among them, Nyxoah secured the most recent funding round in December, 2025.

Biotricity - 2026 Company Profile, Team, Funding, Competitors & Financials

Biotricity is a public company based in San Francisco (United States), founded in 2014 by Waqaas Al-Siddiq. It operates as a Developer of medical remote monitoring solutions that help prevent and manage chronic diseases. Biotricity has raised an undisclosed amount in funding. The company has 755 active competitors, including 178 funded and 54 that have exited. Its top competitors include companies like Withings, iRhythm Tech and Eko.

Company Details

Developer of medical remote monitoring solutions that help prevent and manage chronic diseases. It offers Mobile Cardiac Telemetry wearable medical cardiac monitoring solution. The flagship product bioflux consists of an ECG monitoring device, software†and access to a monitoring lab to diagnose Cardiovascular Disease (CVD) or Coronary Heart Disease (CHD), is an ambulatory monitor that detects arrhythmias, performs remote MCT diagnostic monitoring.

Key Metrics

Founded Year

2014

Location

San Francisco, United States

Stage

Public

Latest Funding Round

Post IPO, Mar 25, 2024, $*****

Investors

SWK Holdings & 3 more

Ranked

9^th among 755 active competitors

Annual Revenue

$13.8M as on Mar 31, 2025

Employee Count

56 as on Apr 30, 2026

Investment & Acquisitions

MD Matrix

Similar Companies

Withings & 747 more

Exit Details

Public

View Biotricity's full profile

Biotricity is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
BIOTRICITY INC. CIN: 1630113 , United States, Active	Jan 24, 2011	$13.8M (As on Mar 31, 2025)	55 (As on Dec 31, 2023)	-
BIOTRICITY INC. CIN: 20231715270 , United States, Active	Jul 07, 2023	-	-	-

Biotricity got listed on Jun 03, 2016.

Click here to take a look at Biotricity's IPO in detail

Biotricity has raised funding over 6 rounds. Its first funding round was on Feb 22, 2016. Biotricity has 4 institutional investors.

Here is the list of recent funding rounds of Biotricity:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 25, 2024	4539054	Post IPO	1916700	9389516	6142893	1487276
Sep 01, 2022	1078953	Grant (prize money)	5015779	1842138	4994976	HHS
Aug 07, 2020	9961574	Post IPO	6568786	3462959	8132697	1059883

Access funding benchmarks and valuations. Sign up today!

View details of Biotricity's funding rounds and investors

The founders of Biotricity is Waqaas Al-Siddiq. Waqaas Al-Siddiq is the CEO of Biotricity.

Here are the details of Biotricity's key team members:

Waqaas Al-Siddiq: Co-Founder & CEO of Biotricity.
Contact Info: 1 email address

View details of Biotricity's Founder profiles and Board Members

Biotricity's employee count trend

Biotricity has 56 employees as of Apr 26. Here is Biotricity's employee count trend over the years:

Uncover Biotricity's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Biotricity include Withings, iRhythm Tech and Eko. Here is the list of Top 10 competitors of Biotricity, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Withings 2008, Moulineaux (France), Acquired	Developer of an array of connected products	$93.8M	Bpifrance, Gilde Healthcare & 8 others	83/100
2nd	iRhythm Tech 2006, San Francisco (United States), Public	Provider of cloud-based cardiac rhythm monitoring devices	$98.9M	UNC Kenan-Flagler Private Equity, Norwest ... & 12 others	73/100
3rd	Eko 2012, Oakland (United States), Series D	Provider of AI-based remote patient monitoring platform for cardiac health	$195M	Artis Ventures, EDBI & 33 others	73/100
4th	Jawbone 1997, San Francisco (United States), Series F	Provider of wearable devices for activity and sleep tracking	$877M	Sequoia Capital, Kleiner Perkins & 35 others	67/100
5th	Elfie 2020, Singapore (Singapore), Series A	Developer of a digital health platform rewarding users for health monitoring	$12M	White Star Capital, Integra Partners & 4 others	66/100
6th	Nyxoah 2009, Mont Saint Guibert (Belgium), Public	Provider of a neurostimulation device for obstructive sleep apnea treatments	$88.7M	Cochlear, Gilde Healthcare & 7 others	66/100
7th	Onera 2018, Palo Alto (United States), Series C	Developer of a wearable sleep monitoring system	$60.2M	EQT, Innovation Industries & 10 others	64/100
8th	Welltory 2016, Redwood City (United States), Seed	Online health and wellness tracking and training platform	$1M	Braavo, Altair Capital & 6 others	63/100
9th	Biotricity 2014, San Francisco (United States), Public	Developer of medical remote monitoring solutions that help prevent and manage chronic diseases	-	SWK Holdings, National Research Council Canada ... & 2 others	61/100
10th	Element Science 2013, San Francisco (United States), Series C	Wearable therapeutic device for treating sudden cardiac arrest	$193M	Deerfield, Qiming & 4 others	61/100